1 Min Read
May 15 (Reuters) - Newron Pharmaceuticals SpA :
* Zambon launches Xadago (Safinamide) for patients with mid- to late-stage Parkinson’s disease in Germany Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.